Purpose Long‐term endothelial cell density changes and visual and refractive outcomes after descemetic (d) and predescemetic (pd) deep anterior lamellar keratoplasty (DALK) using the big‐bubble technique in eyes with keratoconus. Methods Retrospective, consecutive, non‐comparative, case series analysis of 95 eyes that have undergone DALK for keratoconus using the big‐bubble technique with at least 1 year of follow‐up. Big‐bubble was achieved in 74 (77.9%) eyes (dDALK), whereas 21 (22.1%) eyes underwent manual lamellar dissection (pdDALK) because of failed big‐bubble. Results Descemet ruptures occurred in 13 of 95 cases (13.7%). Five ruptures (5.3%) were converted to penetrating keratoplasty. Mean length of follow‐up was 5.3 years (range, 1‐8 years). Postoperative best spectacle‐corrected visual acuity was significantly better in dDALK group than in pdDALK group at years 1 and 2. But, at the final examinations, there was no significant difference between the study groups (0.25 ± 0.22 logarithm of the minimum angle of resolution in dDALK group and 0.33 ± 0.15 logarithm of the minimum angle of resolution in pdDALK group; p = 0.12). The 2 groups were comparable regarding astigmatism and spherical equivalent refractive error throughout the follow‐up period. Mean endothelial cell loss was 22.5 ± 17.9% at last follow‐up with most of the loss occurring in the first year (8.7% ± 5.6%). Stromal graft rejection episodes occurred in 3 eyes (3.2%), which resolved with appropriate therapy. Conclusion DALK using the big‐bubble technique is effective in patients with keratoconus. In DALK, manual lamellar dissection is a reasonable alternative when big‐bubble separation of the Descemet membrane is not achieved.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.